 ranitidin certain cellular immun respons asymptomat hiv-infect individu human immunodefici viru hiv infect progress impair immunocompet opportunist infect malign double-blind placebo-control studi potenti impact immunomodul oral ranitidin mg day hiv-posit patient cdc group II clinic sign infect agent sever immunolog paramet hiv infect impair earli hiv infect spontan vitro interferon-alpha-stimul natur killer cell activ ranitidine-tr patient contrast decreas nontreat patient group t-cell blastogenesi stimul solubl receptor serum ranitidine-tr patient nontreat patient ranitidin treatment cell count signific improv immunocompet studi small present result need trial immunomodul ranitidin hiv-infect individu